Weill Cornell Medicine | New York Presbyterian
Dr. Nasser K. Altorki is the Vice Chairman of Cardiothoracic Surgery and the Chief of the Division of Thoracic Surgery at the New York-Presbyterian Hospital and is the David B. Skinner Professor of Cardiothoracic Surgery at Weill Cornell Medical College. He is also leader of the Experimental Therapeutics Program at the Sandra and Edward Meyer Cancer Center and Director of the Neuberger Berman Lung Cancer Research Center.
Beyond his expertise in the surgical treatment of lung cancer and other chest malignancies, he has a longstanding interest in studying the immune landscape as well as immunotherapy for early-stage lung cancer and has led several trials of adjuvant and neoadjuvant immunotherapy in early-stage lung cancer. Dr. Altorki has served as the principal investigator on a number of national and international clinical trials and has written numerous manuscripts and book chapters on lung cancer screening, staging and management of early lung cancer.
Angiocrine Bioscience: Stockholder; Astra Zeneca (Individual(s) Involved: Self): Grant/Research Support, Research Advisory Committee; Roche / Genentech (Individual(s) Involved: Self): Grant/Research Support; TMRW (Individual(s) Involved: Self): Stockholder, Stocks; View Point Medical (Individual(s) Involved: Self): Other Financial or Material Support, Stockholder, Stocks
Friday, October 14, 2022
3:35 PM – 5:10 PM
Friday, October 14, 2022
3:40 PM – 4:00 PM
Friday, October 14, 2022
4:50 PM – 5:10 PM